133 related articles for article (PubMed ID: 32057323)
21. Proceedings from the 2022 Consensus Conference to Implement Optimal Venous Thromboembolism Prophylaxis in Trauma.
Haut ER; Byrne JP; Price MA; Bixby P; Bulger EM; Lake L; Costantini T
J Trauma Acute Care Surg; 2023 Mar; 94(3):461-468. PubMed ID: 36534056
[TBL] [Abstract][Full Text] [Related]
22. How We Manage Pediatric Deep Venous Thrombosis.
Betensky M; Bittles MA; Colombani P; Goldenberg NA
Semin Intervent Radiol; 2017 Mar; 34(1):35-49. PubMed ID: 28265128
[TBL] [Abstract][Full Text] [Related]
23. Implementing thrombosis guidelines in cancer patients: a review.
Farge-Bancel D; Bounameaux H; Brenner B; Büller HR; Kakkar A; Pabinger I; Streiff M; Debourdeau P
Rambam Maimonides Med J; 2014 Oct; 5(4):e0041. PubMed ID: 25386357
[TBL] [Abstract][Full Text] [Related]
24. Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences.
Wiercioch W; Nieuwlaat R; Akl EA; Kunkle R; Alexander KE; Cuker A; Rajasekhar A; Alonso-Coello P; Anderson DR; Bates SM; Cushman M; Dahm P; Guyatt G; Iorio A; Lim W; Lyman GH; Middeldorp S; Monagle P; Mustafa RA; Neumann I; Ortel TL; Rochwerg B; Santesso N; Vesely SK; Witt DM; Schünemann HJ
Blood Adv; 2020 May; 4(10):2351-2365. PubMed ID: 32453843
[TBL] [Abstract][Full Text] [Related]
25. Appraisal of Clinical Practice Guideline: Role of Physical Therapists in the Management of Individuals at Risk for or Diagnosed With Venous Thromboembolism: Evidence-Based Clinical Practice Guideline 2022.
Gosselink R
J Physiother; 2023 Oct; 69(4):276. PubMed ID: 37612231
[No Abstract] [Full Text] [Related]
26. Mechanisms and biomarkers of cancer-associated thrombosis.
Kim AS; Khorana AA; McCrae KR
Transl Res; 2020 Nov; 225():33-53. PubMed ID: 32645431
[TBL] [Abstract][Full Text] [Related]
27. Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented.
Farge D; Bournet B; Conroy T; Vicaut E; Rak J; Zogoulous G; Barkun J; Ouaissi M; Buscail L; Frere C
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32155940
[TBL] [Abstract][Full Text] [Related]
28. Primary Thromboprophylaxis in Ambulatory Pancreatic Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Frere C; Crichi B; Bournet B; Canivet C; Abdallah NA; Buscail L; Farge D
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722064
[TBL] [Abstract][Full Text] [Related]
29. Central Venous Catheter Thrombosis in Cancer: A Multi-Centre Retrospective Study Investigating Risk Factors and Contemporary Trends in Management.
Haggstrom L; Parmar G; Brungs D
Clin Med Insights Oncol; 2020; 14():1179554920953097. PubMed ID: 32943968
[TBL] [Abstract][Full Text] [Related]
30. Management of Cancer-Associated Thrombosis: An Evolving Area.
Frere C; Connors JM; Farge D
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33081109
[TBL] [Abstract][Full Text] [Related]
31. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
Agnelli G; Becattini C; Meyer G; Muñoz A; Huisman MV; Connors JM; Cohen A; Bauersachs R; Brenner B; Torbicki A; Sueiro MR; Lambert C; Gussoni G; Campanini M; Fontanella A; Vescovo G; Verso M;
N Engl J Med; 2020 Apr; 382(17):1599-1607. PubMed ID: 32223112
[TBL] [Abstract][Full Text] [Related]
32. Treatment of venous thromboembolism in cancer patients: The dark side of the moon.
Becattini C; Di Nisio M; Franco L; Lee A; Agnelli G; Mandalà M
Cancer Treat Rev; 2021 May; 96():102190. PubMed ID: 33812338
[TBL] [Abstract][Full Text] [Related]
33. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.
Lyman GH; Carrier M; Ay C; Di Nisio M; Hicks LK; Khorana AA; Leavitt AD; Lee AYY; Macbeth F; Morgan RL; Noble S; Sexton EA; Stenehjem D; Wiercioch W; Kahale LA; Alonso-Coello P
Blood Adv; 2021 Feb; 5(4):927-974. PubMed ID: 33570602
[TBL] [Abstract][Full Text] [Related]
34. Drug-drug interaction (DDI) with direct oral anticoagulant (DOAC) in patients with cancer.
Sebuhyan M; Crichi B; Abdallah NA; Bonnet C; Deville L; Marjanovic Z; Farge D
J Med Vasc; 2020 Nov; 45(6S):6S31-6S38. PubMed ID: 33276942
[TBL] [Abstract][Full Text] [Related]
35. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.
Farge D; Frere C; Connors JM; Khorana AA; Kakkar A; Ay C; Muñoz A; Brenner B; Prata PH; Brilhante D; Antic D; Casais P; Guillermo Esposito MC; Ikezoe T; Abutalib SA; Meillon-García LA; Bounameaux H; Pabinger I; Douketis J;
Lancet Oncol; 2022 Jul; 23(7):e334-e347. PubMed ID: 35772465
[TBL] [Abstract][Full Text] [Related]
36. Cancer-associated venous thromboembolism.
Khorana AA; Mackman N; Falanga A; Pabinger I; Noble S; Ageno W; Moik F; Lee AYY
Nat Rev Dis Primers; 2022 Feb; 8(1):11. PubMed ID: 35177631
[TBL] [Abstract][Full Text] [Related]
37. Modulation of Cellular NAD
Cao W; Zhu MY; Lee SH; Lee SB; Kim HJ; Park BO; Yoon CH; Khadka D; Oh GS; Shim H; Kwak TH; So HS
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769515
[TBL] [Abstract][Full Text] [Related]
38. The Risk Factors of VTE and Survival Prognosis of Patients With Malignant Cancer: Implication for Nursing and Treatment.
Qi Y; Hu X; Chen J; Ying X; Shi Y
Clin Appl Thromb Hemost; 2020; 26():1076029620971053. PubMed ID: 33119403
[TBL] [Abstract][Full Text] [Related]
39. Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC).
Rafii H; Frère C; Benzidia I; Crichi B; Andre T; Assenat E; Bournet B; Carpentier A; Connault J; Doucet L; Durant C; Emmerich J; Gris JC; Hij A; Le Hello C; Madelaine I; Messas E; Ndour A; Villiers S; Marjanovic Z; Ait Abdallah N; Yannoutsos A; Farge D
J Med Vasc; 2020 Feb; 45(1):28-40. PubMed ID: 32057323
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
